A. Groth

867 total citations
25 papers, 626 citations indexed

About

A. Groth is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A. Groth has authored 25 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 6 papers in Epidemiology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A. Groth's work include Atrial Fibrillation Management and Outcomes (6 papers), Diabetes Treatment and Management (6 papers) and Cardiac Arrhythmias and Treatments (5 papers). A. Groth is often cited by papers focused on Atrial Fibrillation Management and Outcomes (6 papers), Diabetes Treatment and Management (6 papers) and Cardiac Arrhythmias and Treatments (5 papers). A. Groth collaborates with scholars based in Germany, United Kingdom and United States. A. Groth's co-authors include Thomas Wilke, Ulf Maywald, S. Mueller, M. Pfannkuche, Frank Verheyen, Roland Linder, Rupert Bauersachs, G. Breithardt, Andreas Fuchs and Thomas Kohlmann and has published in prestigious journals such as SHILAP Revista de lepidopterología, Thrombosis and Haemostasis and Diabetes Research and Clinical Practice.

In The Last Decade

A. Groth

24 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Groth Germany 12 386 125 117 82 67 25 626
Antonio Ciaccia Canada 10 267 0.7× 69 0.6× 138 1.2× 33 0.4× 44 0.7× 16 473
Elizabeth S. Mearns United States 15 261 0.7× 145 1.2× 183 1.6× 162 2.0× 42 0.6× 34 672
Morten Olesen Denmark 11 436 1.1× 133 1.1× 39 0.3× 23 0.3× 52 0.8× 33 655
Anselm K. Gitt Germany 9 511 1.3× 53 0.4× 90 0.8× 321 3.9× 49 0.7× 28 865
Mar Martín‐Pérez Spain 10 204 0.5× 64 0.5× 35 0.3× 43 0.5× 24 0.4× 22 423
Basil S. Lewis Israel 15 863 2.2× 130 1.0× 167 1.4× 67 0.8× 105 1.6× 42 1.1k
Wael Al Mahmeed United Arab Emirates 12 396 1.0× 67 0.5× 81 0.7× 48 0.6× 35 0.5× 39 529
Amanda Bruno United States 13 268 0.7× 37 0.3× 148 1.3× 25 0.3× 67 1.0× 49 494
D.E. van Diermen Netherlands 11 218 0.6× 43 0.3× 120 1.0× 104 1.3× 24 0.4× 26 520

Countries citing papers authored by A. Groth

Since Specialization
Citations

This map shows the geographic impact of A. Groth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Groth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Groth more than expected).

Fields of papers citing papers by A. Groth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Groth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Groth. The network helps show where A. Groth may publish in the future.

Co-authorship network of co-authors of A. Groth

This figure shows the co-authorship network connecting the top 25 collaborators of A. Groth. A scholar is included among the top collaborators of A. Groth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Groth. A. Groth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilke, Thomas, et al.. (2019). Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany. Clinical Therapeutics. 42(1). 130–143.e3. 8 indexed citations
2.
3.
4.
Mueller, S., A. Groth, Wilhelmine Meeraus, et al.. (2018). Primary data, claims data, and linked data in observational research: the case of COPD in Germany. Respiratory Research. 19(1). 161–161. 12 indexed citations
5.
Wilke, Thomas, et al.. (2018). PGI1 - ADVERSE EVENTS ASSOCIATED WITH THE TREATMENT OF INFLAMMATORY BOWEL DISEASE IN GERMANY. Value in Health. 21. S142–S142. 2 indexed citations
6.
7.
8.
Wilke, Thomas, A. Groth, Andreas Fuchs, M. Pfannkuche, & Ulf Maywald. (2017). Persistence with VKA treatment in newly treated atrial fibrillation patients: an analysis based on a large sample of 38,076 German patients. European Journal of Clinical Pharmacology. 73(11). 1437–1447. 7 indexed citations
9.
Groth, A., et al.. (2017). Incidence and Prevalence of Epilepsy in Germany. Value in Health. 20(9). A720–A720. 3 indexed citations
10.
11.
Wilke, Thomas, Bjorn P. Berg, A. Groth, et al.. (2016). Healthcare Burden and Costs Associated with Urinary Tract Infections in Type 2 Diabetes Mellitus Patients: An Analysis Based on a Large Sample of 456,586 German Patients. ˜The œNephron journals/Nephron journals. 132(3). 215–226. 10 indexed citations
12.
Wilke, Thomas, S. Mueller, A. Groth, et al.. (2015). Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study. Journal of Diabetes & Metabolic Disorders. 15(1). 28–28. 3 indexed citations
13.
14.
Wilke, Thomas, A. Groth, S. Mueller, et al.. (2015). Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456,586 German T2DM patients. Journal of Diabetes and its Complications. 29(8). 1015–1023. 49 indexed citations
15.
Wilke, Thomas, et al.. (2014). Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-use. Journal of Thrombosis and Thrombolysis. 40(1). 97–107. 29 indexed citations
16.
Wilke, Thomas, A. Groth, Andreas Fuchs, et al.. (2014). Real life treatment of diabetes mellitus type 2 patients: An analysis based on a large sample of 394,828 German patients. Diabetes Research and Clinical Practice. 106(2). 275–285. 17 indexed citations
17.
18.
Wilke, Thomas, A. Groth, Sabrina Müller, et al.. (2013). Interruption/Bridging of VKA Treatment of Patients with Atrial Fibrillation: Analysis of Incidence and Clinical Outcomes Based on a German Claims Based Data Set. Value in Health. 16(7). A517–A517. 1 indexed citations
19.
Wilke, Thomas, A. Groth, S. Mueller, et al.. (2012). Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. EP Europace. 15(4). 486–493. 267 indexed citations
20.
Wilke, Thomas, A. Groth, S. Mueller, et al.. (2012). How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus. The European Journal of Health Economics. 14(3). 551–568. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Ciaccia Breakdown of academic impact, for papers by Elizabeth S. Mearns Breakdown of academic impact, for papers by Morten Olesen Breakdown of academic impact, for papers by Anselm K. Gitt Breakdown of academic impact, for papers by Mar Martín‐Pérez Breakdown of academic impact, for papers by Basil S. Lewis Breakdown of academic impact, for papers by Wael Al Mahmeed Breakdown of academic impact, for papers by Amanda Bruno Breakdown of academic impact, for papers by D.E. van Diermen
Rankless by CCL
2026